Friday, April 28, 2023

Emerson Electric Co. (EMR) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Emerson Electric Co. (EMR). Below are some highlights from the above linked analysis:

Company Description: Emerson Electric Co. designs and supplies product technology, and delivers engineering services and solutions to a wide range of industrial, commercial and consumer markets around the world.

Tuesday, April 25, 2023

Why Dividend Growth Stocks Are Evil

I can't carry on anymore. The secret has become too much of a burden and it must be shared with the masses. This will shock some and enrage others, but it must be said, and I should be the one to say it. Dividend stocks are evil and they will eventually lead to the collapse of western civilization as we know it. There, I said it and here is why I believe it...

Friday, April 21, 2023

Archer Daniels Midland Company (ADM) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Archer Daniels Midland Company (ADM). Below are some highlights from the above linked analysis:

Company Description: Archer-Daniels-Midland Co. is one of the world's leading agribusiness concerns, with major market positions in agricultural processing and merchandising.

Friday, April 14, 2023

United Parcel Service, Inc. (UPS) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of United Parcel Service, Inc. (UPS). Below are some highlights from the above linked analysis:

Company Description: United Parcel Service, Inc. is the world's largest express delivery company, UPS has established itself as a facilitator of e-commerce.

Friday, April 7, 2023

Abbott Laboratories (ABT) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Abbott Laboratories (ABT). Below are some highlights from the above linked analysis:

Company Description: This diversified health care products company is now focused on nutritionals, diagnostics, generic drugs, and medical devices, following the spinoff of its R&D-based prescription pharmaceuticals business at the beginning of 2013.